These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 195972)

  • 1. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis.
    Davies M; Mawer EB; Adams PH
    J Clin Endocrinol Metab; 1977 Aug; 45(2):199-208. PubMed ID: 195972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phenytoin on bone and vitamin D metabolism.
    Bell RD; Pak CY; Zerwekh J; Barilla DE; Vasko M
    Ann Neurol; 1979 Apr; 5(4):374-8. PubMed ID: 220903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D metabolism and parathyroid function in man.
    Mawer EB; Backhouse J; Hill LF; Lumb GA; De Silva P; Taylor CM; Stanbury SW
    Clin Sci Mol Med; 1975 May; 48(5):349-65. PubMed ID: 165031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).
    Shiraki M; Orimo H; Ito H; Akiguchi I; Nakao J; Takahashi R; Ishizuka S
    Endocrinol Jpn; 1985 Apr; 32(2):305-15. PubMed ID: 2995014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis.
    Berl T; Berns AS; Huffer WE; Alfrey AC; Arnaud CD; Schrier RR
    Contrib Nephrol; 1980; 18():72-81. PubMed ID: 6243528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
    Gallagher JC; Riggs BL; DeLuca HF
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
    Lindholm TS; Sevastikoglou JA; Lindgren U
    Clin Orthop Relat Res; 1978 Sep; (135):226-31. PubMed ID: 709935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?
    Kanis JA; Cundy T; Bartlett M; Smith R; Heynen G; Warner GT; Russell RG
    Br Med J; 1978 May; 1(6124):1382-6. PubMed ID: 647302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failure.
    Christiansen C; Røodbro P; Christensen MS; Naestoft J; Hartnack B; Transbøol I
    Contrib Nephrol; 1980; 18():139-46. PubMed ID: 6243527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of bile on intestinal calcium and vitamin D absorption. Animal experiment studies in swine].
    Braun F
    Wien Klin Wochenschr Suppl; 1986; 166():1-23. PubMed ID: 3008448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
    Berl T; Berns AS; Hufer WE; Hammill K; Alfrey AC; Arnaud CD; Schrier RW
    Ann Intern Med; 1978 Jun; 88(6):774-80. PubMed ID: 208439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1,25-dihydroxycholecalciferol on 47calcium absorption in post-menopausal osteoporosis.
    Caniggia A; Vattimo A
    Clin Endocrinol (Oxf); 1979 Jul; 11(1):99-103. PubMed ID: 519874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
    Kiilerich S; Christiansen C; Christensen MS; Naestoft J
    Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in osteoporosis.
    Davies M; Mawer EB; Adams PH
    Calcif Tissue Res; 1977 May; 22 Suppl():74-7. PubMed ID: 199338
    [No Abstract]   [Full Text] [Related]  

  • 18. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.
    Gallagher JC; Riggs BL; Eisman J; Hamstra A; Arnaud SB; DeLuca HF
    J Clin Invest; 1979 Sep; 64(3):729-36. PubMed ID: 468987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolism of a physiological dose of radioactive cholecalciferol (vitamin D3) to its hydroxylated metabolites in man.
    Stanbury SW; Mawer EB
    Clin Sci (Lond); 1980 Jun; 58(6):523-35. PubMed ID: 6253118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of vitamin D3 and its metabolites 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on callus mineralization in rats with femoral fracture].
    Blazhevich NV; Sergeev IN; Arkhapchev IuP; Isaeva VA; Spirichev VB
    Vopr Med Khim; 1982; 28(6):98-105. PubMed ID: 6297167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.